Align Technology, Inc. (NASDAQ:ALGN) Shares Sold by Personal CFO Solutions LLC

Personal CFO Solutions LLC lowered its stake in shares of Align Technology, Inc. (NASDAQ:ALGN) by 4.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,065 shares of the medical equipment provider’s stock after selling 85 shares during the quarter. Personal CFO Solutions LLC’s holdings in Align Technology were worth $1,103,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ALGN. Conning Inc. boosted its position in Align Technology by 2.1% in the fourth quarter. Conning Inc. now owns 1,026 shares of the medical equipment provider’s stock valued at $548,000 after buying an additional 21 shares during the last quarter. Harel Insurance Investments & Financial Services Ltd. purchased a new stake in Align Technology in the 4th quarter worth approximately $48,000. Schaper Benz & Wise Investment Counsel Inc. WI boosted its position in Align Technology by 0.6% in the 3rd quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 4,993 shares of the medical equipment provider’s stock worth $1,635,000 after purchasing an additional 29 shares in the last quarter. First Horizon Advisors Inc. boosted its position in Align Technology by 11.5% in the 3rd quarter. First Horizon Advisors Inc. now owns 281 shares of the medical equipment provider’s stock worth $91,000 after purchasing an additional 29 shares in the last quarter. Finally, JustInvest LLC boosted its position in Align Technology by 4.6% in the 4th quarter. JustInvest LLC now owns 658 shares of the medical equipment provider’s stock worth $352,000 after purchasing an additional 29 shares in the last quarter. Hedge funds and other institutional investors own 85.84% of the company’s stock.

Shares of ALGN traded down $17.55 during midday trading on Tuesday, hitting $561.99. The company had a trading volume of 13,351 shares, compared to its average volume of 544,819. The company’s 50-day simple moving average is $569.55 and its 200-day simple moving average is $443.08. The firm has a market capitalization of $44.31 billion, a P/E ratio of 26.37, a P/E/G ratio of 4.07 and a beta of 1.68. Align Technology, Inc. has a 1 year low of $127.88 and a 1 year high of $634.46.

Align Technology (NASDAQ:ALGN) last announced its quarterly earnings data on Tuesday, February 2nd. The medical equipment provider reported $2.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.14 by $0.47. The business had revenue of $834.50 million during the quarter, compared to analysts’ expectations of $793.56 million. Align Technology had a return on equity of 68.99% and a net margin of 76.00%. The business’s quarterly revenue was up 28.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.53 EPS. On average, analysts anticipate that Align Technology, Inc. will post 3.34 EPS for the current year.

In other news, Director George J. Morrow sold 15,000 shares of Align Technology stock in a transaction dated Monday, February 8th. The stock was sold at an average price of $624.60, for a total value of $9,369,000.00. Following the completion of the transaction, the director now owns 26,680 shares in the company, valued at approximately $16,664,328. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Andrea Lynn Saia sold 2,500 shares of Align Technology stock in a transaction dated Friday, November 27th. The shares were sold at an average price of $470.92, for a total value of $1,177,300.00. The disclosure for this sale can be found here. Insiders sold a total of 23,000 shares of company stock valued at $13,886,765 in the last quarter. Company insiders own 1.20% of the company’s stock.

Several equities research analysts have commented on ALGN shares. Barclays upped their price objective on Align Technology from $475.00 to $555.00 and gave the stock an “equal weight” rating in a research report on Thursday, February 4th. SVB Leerink increased their target price on Align Technology from $620.00 to $680.00 and gave the company an “outperform” rating in a research report on Thursday, February 4th. Stifel Nicolaus increased their target price on Align Technology from $460.00 to $515.00 and gave the company a “buy” rating in a research report on Wednesday, October 28th. Zacks Investment Research lowered Align Technology from a “buy” rating to a “sell” rating and set a $563.00 target price on the stock. in a research report on Wednesday, December 23rd. Finally, Credit Suisse Group increased their target price on Align Technology from $618.00 to $630.00 and gave the company an “outperform” rating in a research report on Thursday, February 4th. Two research analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have given a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $481.71.

About Align Technology

Align Technology, Inc, a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services.

Featured Story: Fundamental Analysis and Individual Investors

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.